GPR183 and myalgic encephalomeyelitis/chronic fatigue syndrome: Because EBI2 has been found to be highly expressed in PBMC (B, T, NK, monocytes, and granulocytes) during EBV reactivation [4,6,7], this marker has identified an EBV-induced subtype of ME/CFS [3].